For instance, tumor associated macrophages (TAMs) and regulatory T cells (Tregs) have been regarded to be protumor (25, 26), while CD8+ T cells are associated with improved clinical outcomes and response to immunotherapy (27–29). This evidence concerns the gene CD8A and neoplasm.